American pharmaceutical companies are increasingly forming alliances with Chinese biotech firms, marking a major shift in global pharma dynamics. Nearly 30% of
Big Pharma is increasingly partnering with Chinese firms, with 30% of 2024 deals involving significant investments. China’s advanced drug development and rapid
Foreign adversaries like Russia and China target laid-off U.S. federal employees, particularly those with security clearances, exploiting vulnerabilities from recent layoffs. Digital
February 2025 saw unprecedented records in China’s electric vehicle (EV) sales, defying the traditional post-Spring Festival slowdown. XPeng leads with a massive